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BACKGROUND: Consumption of wholegrain (WG) products may protect against colon and rectal cancer.
METHODS: The associations between total and individual WG product consumption and colon and rectal cancer risk were
prospectively examined using data on 461 incident cases of colon cancer and 283 incident cases of rectal cancer that developed
during 10.6 years (median) of follow-up among 26630 men and 29189 women taking part in the Diet, Cancer and Health cohort.
Incidence rate ratios (IRRs) of colon and rectal cancer related to total or individual WG product intake were calculated using Cox
regression.
RESULTS: Higher WG product intake was associated with lower risk of colon cancer and rectal cancer in men. The adjusted IRR (95%
CI) was 0.85 (0.77–0.94) for colon cancer and 0.90 (0.80–1.01) for rectal cancer per daily 50g increment in intake. For colon cancer
the association was confined to intake of WG bread in particular. No consistent associations between total or individual
WG product consumption and colon or rectal cancer risk were observed in women.
CONCLUSION: The findings suggest that higher total WG product intake is associated with a lower risk of colon and perhaps rectal
cancer in men, but not in women.
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Wholegrain (WG) products are widely recommended as part of a
healthy diet in many countries, but their significance for cancer
prevention is not understood. With respect to colon and rectal
cancer, a preventable effect of WG products seem plausible as they
are rich in a variety of components including dietary fibres and
other bioactive substances such as vitamins (vitamins belonging to
the B group and vitamin E), minerals (e.g. magnesium, selenium),
antioxidants, phytooestrogens and other phytochemicals which all
are anticipated to influence cancer risk through various mechan-
isms (Slavin, 2004).
Although much data from case–control studies are supportive
of a protective association between WG product intake and
colorectal cancer risk (Jacobs et al, 1998; Levi et al, 1999; La et al,
2003; Slattery et al, 2004), evidence from prospective studies is
limited, including two studies showing a protective association
(Larsson et al, 2005; Schatzkin et al, 2007) and two showing no
overall association (Pietinen et al, 1999; McCullough et al, 2003).
Few studies have focussed, as we have, on specific types of
WG products, although high intake of rye-based products have
been associated with a lower risk of colorectal cancer in some
prospective studies (Pietinen et al, 1999; Larsson et al, 2005).
Due to the inconsistent results and limited number of
prospective studies, the impact of WG product intake on the risk
of colon and rectal cancer is still not clear-cut. Thus, the aim of this
study was to examine the association between intake of total and
individual WG products in relation to risk of colon and rectal
cancer within the Danish Diet, Cancer and Health prospective
cohort study. Wholegrain products, especially WG rye bread, are
one of the stable foods in Denmark where intake is among the
highest in the world. Because of that, the Diet, Cancer and Health
study present a unique setting for a study to contribute to the
further clarification of any potential role of WG products on risk of
colon and rectal cancer. As dietary fibres, one of the proposed
components responsible for the potential protective effect of WG
products, and colorectal cancer risk has already been examined in
the European Prospective Investigation into Nutrition and Cancer
(EPIC) (Bingham et al, 2003) (of which the present cohort is part),
specific fibre analyses are not included in this study.
SUBJECTS AND METHODS
The Diet, Cancer and Health study is a prospective cohort study
(Tjonneland et al, 2007). In brief, between 1993 and 1997, 160725
Danish men and women were invited to participate, the inclusion
criteria being age 50–64 years, living in the greater Copenhagen
and Aarhus areas, born in Denmark and not registered with a
previous cancer diagnosis in the Danish Cancer Registry (Storm
et al, 1997). Subjects were identified by the unique ten-digit
identification number, allocated to every citizen by the Danish
Central Population Registry, of whom 27178 men and 29875
women participated. All participants attended one of two Received 9 April 2010; revised 15 June 2010; accepted 21 June 2010
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www.bjcancer.comestablished study centres in Copenhagen and Aarhus. The Diet,
Cancer and Health cohort study and the present study were
approved by the Regional Ethical Committees on human studies in
Copenhagen and Aarhus, and by the Danish Data Protection
Agency. The present study is based on data from 26630 male
participants and 29189 female participants after exclusion of
subjects with a previous cancer diagnosis before baseline (n¼571)
and subjects who did not fill in the lifestyle questionnaire (n¼37).
In addition, we further excluded 285 men and 341 women because
of missing information on variables considered in the analyses.
Diet was measured by a 192-item food frequency questionnaire
(FFQ) that each cohort participants received by mail before their visit
to one of the two study centres. A description of the development and
validation of this FFQ has been published previously (Overvad et al,
1991; Tjonneland et al, 1991, 1992; Haraldsdottir et al, 1994). The FFQ
was designed specifically for the study population, aiming to capture
the average intake of different food and beverage items over the past
12 months before study inclusion. Dietary consumption was assessed
in 12 categories of predefined responses, ranging from ‘never’ to ‘8
times or more per day’. Daily intakes of foods and nutrients were
calculated for each participant by the software programme FoodCalc
(www.ibt.ku.dk/jesper/foodcalc/) using population-specific standar-
dised recipes and portion sizes. We considered total daily intake
(g per day) of WG products as the main exposure variable. This food
group consisted of intake of WG rye bread, WG bread and oatmeal.
Secondary analyses were conducted for the three individual WG
products (WG rye bread, WG bread and oatmeal).
During the study centre visit, participants also completed a
lifestyle questionnaire including questions regarding social factors,
health status, reproductive factors and lifestyle habits. From
this questionnaire the following information was available: years
of school education, use of hormone replacement therapy (HRT)
and leisure time physical activity. The FFQ and the lifestyle
questionnaire were both processed during the visit by optical
scanning and checked so that missing or unclear information
could be clarified with the participant before he/she left the study
clinic. A few missing values were accepted in the lifestyle
questionnaire, but not in the FFQ. Furthermore, participants had
their anthropometrical measurements (e.g., height and weight)
recorded by trained health professionals at the study clinics. Body
mass index (BMI) was calculated as weight (kg) per height
2 (m
2).
All cohort members were linked to the Central Population
Registry for information on vital status and emigration. Each
cohort member was followed up for colon or rectal cancer from
the date of entry, that is, date of visit to the study centre until the
date of diagnosis of any cancer (except non-melanoma skin
cancer), the date of death, date of emigration or 27 April 2006.
Information on cancer incidence was obtained by linkage to the
Danish Cancer Registry using the personal identification number
of each participant. All individuals in Denmark who are diagnosed
with cancer are registered herein using the Central Population
Registry system (Storm et al, 1997). Definition of colon and rectal
cancer was based on the tenth Revision of the International
Classification of Diseases. Cancers of the colon included tumours
occurring at the colon (C18.0–C18.9 and C19). Proximal colon
tumours included the caecum, appendix, ascending colon, hepatic
flexure, transverse colon and splenic flexure (C18.1–C18.5). Distal
colon tumours included the descending (C18.6) and sigmoid
(C18.7) colon and tumours occurring at the rectosigmoid junction
(C19.9). Colon tumours at overlapping lesions (C18.8) and colon
NOS (C18.9) were grouped among all colon cancers only. Rectal
cancers included tumours occurring at the rectum (C20). Anal
canal tumours were not considered in this analysis.
Statistical analysis
The analyses of the relation between the WG product variables and
colon or rectal cancer rates were based on the Cox proportional
hazard model (including time-dependent variables) using age as
the time axis to ensure that the estimation procedure was based on
comparisons of individuals at the same age, which allowed for age
adjustment to prevent confounding by age. The other time
variable, time under study, was included as a time-dependent
variable modelled by a linear spline with a boundary at 1, 2 and
3 years after entry into the study cohort to allow for a possible
‘healthy-participants’ effect. A linear spline was used because
this allows a steady increase in the rate during the first year of
follow-up (Greenland, 1995b). Tests of effect modification by sex
were performed using the likelihood ratio test. Test for interaction
between sex and total WG product intake revealed a significant
interaction for both colon (P¼0.0496) and rectal cancer
(P¼0.0008). Consequently, data were analysed separately by sex.
All models were adjusted for baseline values of potential colon
or rectal cancer risk factors including BMI (weight (kg) per height
(m)
2; continuous), alcohol intake (g per day; continuous), school
education (low (p7 years), medium (8–10 years) and high (X11
years)), intake of red and processed meat (g per day; continuous)
and use of HRT in women only (never, past or current use).
Furthermore, colon cancer models were adjusted for leisure time
physical activity (includes the six different activities: walking,
cycling, sports, housework, gardening and hobby work; the
number of activities with participation is defined as 40h per
week of activity; continuous) (Johnsen et al, 2006).
All quantitative variables were entered linearly in the Cox model
because this is biologically more reasonable than the step functions
corresponding to categorisation and, furthermore, it increases the
power of the analyses (Greenland, 1995a). The linearity of the
associations was evaluated graphically by linear splines with three
boundaries placed at the quartiles among cases. As we found no
significant departures from linearity, all quantitative variables
were entered linearly in the model (Greenland, 1995b).
In the analyses, WG product variables included intakes in
grams per day of total WG products and individual WG products
(WG rye bread, WG bread and oatmeal). The incidence rate ratios
(IRRs) of the associations of linear WG product variables were
presented as the IRRs associated with a higher intake of 25g per
day (individual WG products) or 50g per day (total WG products)
based on an evaluation of the inter-quartile range among cases
(men and women, colon and rectal cancer cases combined). The
continuous analyses were further supplemented with categorical
analyses. In these categorical analyses, the WG product variables
were categorised into quartiles based on the distribution among
cases (men and women, colon and rectal cancer cases combined).
Two-sided 95% confidence intervals (CIs) for the IRRs were
calculated based on Wald’s test of the Cox regression parameter,
that is, on the log rate ratio scale. The procedure PHREG in SAS
(release 9.1; SAS Institute, Cary, NC, USA) on a TextPad platform
was used for the statistical analyses.
RESULTS
During a median follow-up of 10.6 years, the distributions of
diagnosed cancer cases were as follows: 244 colon cancers
(89 proximal, 140 distal and 15 unknown) and 169 rectal cancers
in men, and 217 colon cancers (84 proximal, 118 distal and
15 unknown) and 114 rectal cancers in women. Baseline
characteristics of the total cohort and cancer cases presented
separately for men and women are given in Table 1. Compared
with the total cohort of men, male colon and rectal cancer cases
had a higher intake of alcohol and red and processed meat and
were less educated. Female colon and rectal cancer cases had a
lower alcohol intake, were less educated and more likely to be
never HRT users compared with the total cohort of women. In
addition, colon cancer cases had a slightly higher intake of red and
processed meat compared with the total cohort of women.
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according to intake of total and individual WG products in men and
women. In men, higher intake of total WG products was associated
with a statistically significant 15% lower incidence rate of colon
cancer (IRR 0.85, 95% CI 0.77–0.94, per each increment in intake of
50g per day) and a borderline statistically significant 10% lower
incidence rate of rectal cancer (IRR 0.90, 95% CI 0.80–1.01, per
each increment in intake of 50g per day). In women, no consistent
associations were observed for either colon or rectal cancer.
Among men, a borderline statistically significant lower risk of
colon cancer was found for higher WG rye bread consumption
(IRR 0.94, 95% CI 0.88–1.01). Higher WG bread intake was
statistically significantly associated with a lower risk of colon
cancer. For every increment in intake of 25g per day, the adjusted
IRR was 0.89 (95% CI 0.82–0.97). Oatmeal consumption was not
associated with the risk of colon cancer among men (Table 2). No
associations were found between any of the individual WG
products and rectal cancer among men and colon or rectal cancer
among women (Table 2).
Among men, intake of total WG products was associated
with a lower risk of both proximal and distal colon cancer
(IRRproximal colon 0.78, 95% CI 0.66–0.92 per each increment in
intake of 50g per day; IRRdistal colon 0.90, 95% CI 0.79–1.02 per
each increment in intake of 50g per day). Higher intakes of WG
rye bread (IRR 0.89, 95% CI 0.79–1.01 per each increment in
intake of 25g per day) and WG bread (IRR 0.88, 95% CI 0.76–1.01
per each increment in intake of 25g per day), but not oatmeal,
were borderline statistically significantly associated with lower risk
of proximal colon cancer. Only a higher intake of WG bread was
associated with a lower risk of distal colon cancer among men (IRR
0.89, 95% CI 0.80–1.00 per each increment in intake of 25g per
day). In women, no associations were observed between intake of
total or individual WG products and risk of either proximal or
distal colon cancer (data not shown).
DISCUSSION
In this population-based prospective cohort of Danish men and
women, we found that higher intake of total WG products was
associated with a significant 15% lower risk of colon cancer, and
also a tendency towards lower risk of rectal cancer among men.
The association with colon cancer risk among men seemed to be
confined to intake of WG bread in particular. We observed no
associations of risk of colon or rectal cancer with either total
consumption of WG products or with individual types of WG
products among women.
The strengths of this study include its prospective design and
high follow-up rate, which eliminates potential recall bias or
Table 1 Baseline characteristics and wholegrain consumption among the total cohort and colon and rectal cancer cases presented separately for men and














Age at baseline, years
Median (5th–95th percentile) 56 (50–64) 59 (51–64) 58 (51–64) 56 (50–64) 58 (51–64) 58 (50–65)
BMI, kgm
–2
Median (5th–95th percentile) 26 (21–33) 26 (21–34) 27 (21–32) 25 (20–34) 26 (20–37) 26 (20–35)
Alcohol intake, g per day
Median (5th–95th percentile) 20 (2–80) 25 (3–82) 22 (3–90) 10 (1–42) 8 (1–41) 6 (1–42)
Red and processed meat intake, g per day
Median (5th–95th percentile) 139 (67–255) 142 (71–260) 140 (58–249) 84 (35–157) 86 (35–154) 84 (26–154)
School education, n (%)
Low (p7years) 9242 (35) 83 (34) 54 (32) 9141 (31) 84 (39) 41 (36)
Medium (8–10 years) 11070 (42) 111 (45) 82 (49) 14672 (50) 98 (45) 55 (48)
High (X11years) 6318 (24) 50 (20) 33 (20) 5376 (18) 35 (16) 18 (16)
Physical activity, a total no. of activities
a
Median (5th–95th percentile) 5 (2–5) 4 (2–5) 5 (2–5) 4 (2–5) 4 (2–5) 4 (2–5)
HRT status, n (%)
Never user — — — 15901 (54) 131(60) 68 (60)
Past user — — — 4522 (15) 30 (14) 16 (14)
Current user — — — 8766 (30) 56 (26) 30 (26)
Total wholegrain products, g per day
Median (5th–95th percentile) 130 (42–267) 115 (37–243) 118 (55–241) 113 (31–224) 113 (38–220) 103 (28–282)
Wholegrain Rye bread, g per day
Median (5th–95th percentile) 63 (20–163) 63 (20–163) 63 (20–163) 63 (11–113) 63 (11–113) 63 (20–113)
Wholegrain bread, g per day
Median (5th–95th percentile) 31 (1–100) 17 (1–100) 31 (1–100) 31 (1–100) 31 (1–100) 31 (1–180)
Oatmeal, g per day
Median (5th–95th percentile) 21 (1–50) 21 (1–50) 4 (1–50) 7 (1–50) 7 (1–50) 4 (1–50)
Abbreviations: BMI¼body mass index; HRT¼hormone replacement therapy.
aThe median refers to the summarised number of the leisure time physical activities, that is,
walking, cycling, sports, gardening, housework and do-it-yourself work. Participation is defined as 40h of activity.
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cases through linkage to the Danish Cancer Registry. Moreover,
comprehensive information was also available on potential
confounders. Our study also had several potential limitations.
First, the relatively small number of both colon and rectal cancer
cases, although with more than 10 years of follow-up (median),
remains a limitation. This is mainly true for colon cancer subsite-
specific analyses and rectal cancer analyses for each sex. Second,
although our dietary assessment method is validated (Tjonneland
et al, 1991, 1992; Haraldsdottir et al, 1994), some measurement
error in the assessment of the dietary intake is inevitable. The use
of a self-administered FFQ that, in addition, was not specifically
developed to estimate WG product intake among our study
population may have contributed to misclassification. This
misclassification because of the prospective design of the study
is probably non-differential and may have caused an attenuation of
results. Finally, although control for potential colon and rectal
cancer risk factors in the analyses did not substantially change the
estimates, as residual confounding from these variables cannot
fully explain the study findings, we cannot exclude the possibility
that the study results have been biased by confounding by
unaccounted factors.
Four cohort studies have explored associations between total
WG product intake and risk of colorectal cancer or its subsites
(Pietinen et al, 1999; McCullough et al, 2003; Larsson et al, 2005;
Schatzkin et al, 2007). Similar to our findings for men, Schatzkin
et al (2007) found in the NIH-AARP Diet and Health study a
significant lower risk of colorectal cancer among men for a higher
WG intake. In contrast, in two other cohort studies no associations
were shown (Pietinen et al, 1999; McCullough et al, 2003). Quite
unexpected, intake of total WG products was not associated with
risk of either colon or rectal cancer among women in our study.
Although these findings agree with results from one previous
cohort study (McCullough et al, 2003), they disagree with results
from two other recent larger cohort studies presenting results
separately for women (Larsson et al, 2005; Schatzkin et al, 2007).
In the Swedish Mammography cohort, Larsson et al (2005)
reported a statistically significant lower risk of colon cancer, but
not rectal cancer, for highest vs lowest WG product intake. In the
above-mentioned NIH-AARP Diet and Health study, there were
also indications of lower risk of colorectal cancer for a higher WG
intake, although the association was nonsignificant and somewhat
weaker than that observed for men in the same cohort (Schatzkin
et al, 2007).
It is unclear why our study suggests an association for men but
not for women. Possible reasons for the apparent lack of
associations between intake of WG products and risk of colon
and rectal cancer among women in our study may concern issues
regarding lack of sufficient variation in intake of WG products
among our female cohort participants to produce an effect, and/or
lack of sufficient statistical power in the female-specific analyses,
as fewer colon and rectal cancer cases were diagnosed in women
than among men. In addition, based on our and the results
obtained from the NIN-AARP Diet and Health study, it could be
speculated whether the effect of WG products is stronger for men
than it is for women. Suggestions of sex-specific effects of other
diet-related factors with the development of colon and rectal
cancer have been indicated previously (Jacobs, 2007) and what
initially motivated us to generally conduct sex-specific analyses.
Nonetheless, the gender-specific differences in associations
observed in this study require further confirmation.
Small experimental and human intervention studies suggest that
in particular WG rye products may hold potential positive effects
in relation to colon and rectal cancer prevention that are superior
to those of other WG cereals (e.g., WG wheat- and oat-based
products; McIntosh et al, 2003; Kallio et al, 2008; Andersson et al,
2010). However, epidemiological data directly examining the
effects of different WG products made from different cereal grains
(e.g., WG rye, WG wheat and oat) on the risk of colon and rectal
cancer are sparse, making comparison of our results with previous
studies limited. With regard to specific types of WG products, a
lower risk of colon cancer among men was most evident for WG
Table 2 Incidence rate ratios (IRR) and 95% CIs for colon and rectal cancer in men and women according to intake of total and individual wholegrain
products, the Danish Diet, Cancer and Health study



















Total wholegrain products (per every 50g increment)
By categories of daily total wholegrain product intake (g per day)
244 0.83 (0.76–0.92) 0.85 (0.77–0.94) 169 0.88 (0.79–0.98) 0.90 (0.80–1.01)
Group 1: p75 (g per day) 61 1.00 1.00 32 1.00 1.00
Group 2: 75 to p115 (g per day) 61 0.91 (0.64–1.30) 0.95 (0.66–1.35) 49 1.40 (0.90–2.19) 1.45 (0.93–2.26)
Group 3: 115 to p160 (g per day) 46 0.66 (0.45–0.96) 0.70 (0.47–1.03) 30 0.81 (0.49–1.33) 0.84 (0.51–1.39)
Group 4: 4160 (g per day) 76 0.56 (0.40–0.78) 0.61 (0.43–0.86) 58 0.82 (0.53–1.26) 0.88 (0.57–1.36)
Wholegrain Rye bread (per every 25g increment)
d 244 0.93 (0.87–1.00) 0.94 (0.88–1.01) 169 0.96 (0.88–1.04) 0.97 (0.89–1.05)
Wholegrain bread (per every 25g increment)
d 244 0.89 (0.82–0.96) 0.89 (0.82–0.97) 169 0.94 (0.86–1.03) 0.95 (0.86–1.04)
Oatmeal (per every 25g increment)
d 244 0.94 (0.77–1.15) 0.95 (0.77–1.17) 169 0.79 (0.61–1.03) 0.80 (0.62–1.04)
Women
Total wholegrain products (per every 50g increment)
By categories of daily total wholegrain product intake (g per day)
217 0.96 (0.86–1.07) 0.98 (0.88–1.10) 114 1.01 (0.87–1.18) 1.02 (0.88–1.19)
Group 1: p75 (g per day) 57 1.00 1.00 38 1.00 1.00
Group 2: 75 to p115 (g per day) 62 1.03 (0.72–1.47) 1.08 (0.75–1.56) 28 0.69 (0.43–1.13) 0.70 (0.43–1.14)
Group 3: 115 to p160 (g per day) 47 1.05 (0.71–1.54) 1.13 (0.77–1.67) 16 0.54 (0.30–0.96) 0.54 (0.30–0.97)
Group 4: 4160 (g per day) 51 0.85 (0.58–1.23) 0.92 (0.63–1.35) 32 0.80 (0.50–1.28) 0.81 (0.50–1.30)
Wholegrain Rye bread (per every 25g increment)
d 217 1.01 (0.92–1.10) 1.01 (0.92–1.11) 114 1.04 (0.92–1.17) 1.04 (0.92–1.18)
Wholegrain bread (per every 25g increment)
d 217 0.96 (0.89–1.05) 0.97 (0.89–1.06) 114 1.04 (0.94–1.16) 1.05 (0.94–1.16)
Oatmeal (per every 25g increment)
d 217 1.12 (0.91–1.38) 1.14 (0.92–1.40) 114 0.80 (0.58–1.11) 0.81 (0.58–1.12)
Abbreviations: IRR¼incidence rate ratio; CI¼confidence interval.
aUnadjusted analysis.
bAnalysis adjusted for body mass index, alcohol intake, school education, intake of red
and processed meat, use of hormone replacement therapy (women only) and leisure time physical activity.
cAnalysis adjusted for body mass index, alcohol intake, school
education and intake of red and processed meat and use of hormone replacement therapy (women only).
dThe variables were mutually adjusted in analyses.
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with higher consumption of WG rye bread was also apparent.
Although this finding was of smaller magnitude in comparison to
that of WG bread, it agrees with results from a Finnish cohort
study in which a preventive role of rye foods in relation to risk of
colorectal cancer in men was also suggested. Although in our study
we reported no beneficial effects of WG rye bread intake in women,
a significant protective effect of rye bread on risk of colon cancer
was observed among women in the Swedish Mammography
Cohort (Larsson et al, 2005). Within our cohort it is assumed
that the WG bread consumed by our cohort participants is mainly
WG wheat based, and thus our data do not strongly indicate
differential effects of WG rye- wheat-based products, but this
needs confirmation by other studies. In contrast, we did not find
that oatmeal intake was associated with the risk of colon or rectal
cancer; however, we cannot rule out whether the limited range of
intake of oatmeal in our study could have contributed to the null
finding for this specific WG product. Future studies should
attempt to examine the associations of risk with specific types of
WG products.
If colon and rectal cancers are aetiologically distinct (Potter,
1996; Wei et al, 2004), proximal and distal colon cancers can also
be considered as different classes of colon cancer (Bufill, 1990;
Iacopetta, 2002). Our results showed that higher total WG product
consumption was associated with a significant lower risk of
proximal colon cancer and an indication of a lower risk of distal
colon cancer as well. Although one large case–control study
reported no association with proximal or distal colon cancer risk
(Hu et al, 2007), our findings are consistent with those of two other
prospective studies showing suggestive protective effects of high
WG consumption in these cancers (Larsson et al, 2005; Schatzkin
et al, 2007). At this point there is no strong indication that a
preventive effect of WG product may vary substantially according
to specific colon subsite.
In conclusion, we found that a higher intake of total WG products
is associated with a lower risk of colon and perhaps also rectal
cancer in men, but not in women. Intake of WG bread in particular
seemed to account for the association between total WG products
and risk of colon cancer in men. Overall, these data, especially for
men, provide further support to the public health message to
increase the intake of WG products in gaining optimal health.
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